Geneious Biologics
L2, 18 Shortland Street
Auckland
1010
Tel: 64-9-379-5064
Fax: 64-9-379-5063
Website: https://biologics.geneious.com
About Geneious Biologics
Geneious Biologics is a next-generation cloud solution specifically designed and purpose-built for enterprises engaged in commercial antibody discovery and screening. Delivered through a modern, user-friendly web interface, Geneious Biologics leverages the power of ‘big data’ to help deliver lifesaving drugs of the future.YEAR FOUNDED:
2004
LEADERSHIP:
CEO: Andrew Steel
CTO: Chris Duran
CCO: Michel Seidelin
FOLLOW GENEIOUS BIOLOGICS:
Tweets by Geneious Biologics
4 articles about Geneious Biologics
-
VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics
11/12/2018
Geneious Biologics has been chosen by the VIB (a Life Sciences Research Institute in Belgium) to support therapeutic biologics discovery at its Discovery Sciences group.
-
Geneious Biologics Annotation Algorithm Beats IgBLAST, MiXCR Says New White Paper
5/1/2018
A white paper released today shows an annotation algorithm developed for Geneious Biologics, a commercial software solution for antibody screening and discovery, outperforms those of open source sequence analysis software IgBLAST and MiXCR.
-
New Release Geneious Biologics Gives Deeper Insight Into Big Data
12/11/2017
Geneious Biologics released major new capability that will allow developers of biological drugs to analyze millions of raw antibody sequences in minutes, accelerating identification of therapeutic antibody candidates.
-
Geneious Biologics Momentum Drives U.S., Europe And Asia Expansion For Biomatters
7/18/2017